Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes

  1. Tavira, B.
  2. Barcenilla, H.
  3. Wahlberg, J.
  4. Achenbach, P.
  5. Ludvigsson, J.
  6. Casas, R.
Revue:
Journal of Diabetes Research

ISSN: 2314-6753 2314-6745

Année de publication: 2018

Volumen: 2018

Type: Article

DOI: 10.1155/2018/9391845 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable